Condition: Perihilar Cholangiocarcinoma · Klatskin Tumor · Bile Duct Cancer · Sponsor: Oslo University Hospital
The study will investigate whether liver transplantation provides increased survival, low side effects and good quality of life in patients with bile duct cancer where the tumor cannot be removed by normal surgery. Analyzes of blood and tissue samples from the tumor will be investigated to see if the analyzes can indicate who may have recurrence of the disease after liver transplantation. Furthermore, the effect of chemotherapy on normal liver and tumor tissues in the liver that are removed during transplantation will be investigated.
This description comes directly from the study's public registry record.
Sheraz Yaqub, MD PhD · +4723073296 · shya@ous-hf.no
Pål-Dag Line, MD PhD · +4723070509 · pline@ous-hf.no
Always discuss trial participation with your own doctor first.
| Oslo university hospital | Oslo, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04993131